Figure 6From: Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial Patient Global Assessment on Day 66 showing percent of subjects claiming lactose tolerance. RP-G28 (n = 40). Placebo (n = 18). p = 0.0389.Back to article page